DRUGS CONTAINING TRIAZASPIRO(5.5)UNDECANE DERIVATIVES AS THE ACTIVE INGREDIENT

Details for Australian Patent Application No. 2002238946 (hide)

Owner ONO PHARMACEUTICAL CO., LTD.

Inventors MITSUYA, Hiroaki; MAEDA, Kenji; SHIBAYAMA, Shiro; TAKAOKA, Yoshikazu

Pub. Number AU-A-2002238946

PCT Pub. Number WO2002/074769

Priority 2001-79611 19.03.01 JP

Filing date 18 March 2002

Wipo publication date 3 October 2002

International Classifications

C07D 471/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/49 - Cinchonan derivatives, e.g. quinine

A61K 031/5377

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002238946

8 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002238947-Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient

2002238945-DRUGS COMPRISING COMBINATION OF TRIAZASPIRO(5,5)UNDECANE DERIVATIVE WITH CYTOCHROME P450 ISOZYME 3A4 INHIBITOR AND/ OR P-GLYCOPROTEIN INHIBITOR